PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cerebral Palsy Effects Might Be Lessened By New Drug Treatment

Cerebral palsy is a lifelong disorder affecting about one out of 300 children in the United States. It characteristically affects movement control, causing muscles to stiffen or jerk.

Cerebral Palsy Effects Might Be Lessened By New Drug Treatment
2012-06-11
CHICAGO, IL, June 11, 2012 (Press-News.org) Cerebral palsy is a lifelong disorder affecting about one out of 300 children in the United States. It characteristically affects movement control, causing muscles to stiffen or jerk. Often, people with this disorder move their limbs awkwardly, and other muscles in the body may be affected as well. Patients with cerebral palsy may also be affected cognitively. The range of severity of symptoms of cerebral palsy is variable...some people are completely dependent on others for every aspect of daily living, and may be confined to bed or wheelchairs, while others are able to function quite normally.

The cause of CP is damage or abnormal development in some part of the brain, usually occurring before or during birth, and occasionally in early childhood. Symptoms and severity vary depending on how much and which part of the brain is afflicted. People with cerebral palsy often rely on crutches or a wheelchair to get around. Some need medication to control seizures, and many need speech therapy. In some cases, cognitive development -- as well as physical development -- is impaired.

Preventing cerebral palsy and lessening its severity are important goals for improving millions of lives. Fortunately, recent research provides hope that a new drug treatment might limit the development of cerebral palsy, if administered early.

Is A New Cerebral Palsy Drug On The Horizon?

The cause of a child's cerebral palsy is sometimes difficult to pinpoint. Doctors now believe that infections during pregnancy underlie many cases of this birth defect. Infections can cause inflammation in the brain, leading to damage in parts that control muscle function. Often though, the cause can be determined by an experienced birth injury lawyer and experts through a careful analysis of the medical records.

The new drug's effectiveness was tested on newborn rabbits with a congenital disposition to a muscle disorder like cerebral palsy. The medication treated an inflammatory response in the rabbits' brains, targeted to the proper part of the brain by combining the drug with nanomolecules that allowed it to reach specific brain cells. Rabbits treated with the drug showed much better ability to control their movements than untreated rabbits did. If it works as well in newborn humans, the drug shows promise for early treatment of brain damage caused by prenatal infections. That could make the impact of cerebral palsy much less severe.

Side effects of the drug and its effectiveness in humans have not yet been determined. Also, improving timely diagnosis of prenatal infection and subsequent inflammation is a part of the puzzle, because treatment must be administered right after birth to be effective.

Cerebral Palsy Drug Would Still Depend On Doctors

Aside from infection, many other factors, including, but not limited to both premature birth and delivery complications, can be contributing causes of cerebral palsy. Because some of these conditions are predictable and preventable, conscientious physicians must monitor women during pregnancy to be on the lookout for infection and premature labor. A failure to monitor can be devastating to the health of both the fetus and mother.

Diagnosing cerebral palsy early is important as well. Pediatric physicians should be on the lookout for unusual weakness or delayed physical development in babies. Starting therapy sooner rather than later should produce a better outcome, even though there is no cure for this condition.

If your child has cerebral palsy, and you feel it may have resulted from medical negligence, contact a skilled Chicago birth injury lawyer to discuss your case and explore your legal options.

The partners at the law firm of Lane & Lane, LLC are highly respected throughout the Illinois legal community. We have more than 130 years of combined legal experience. Our members have held leadership roles in the most prestigious legal organizations at the local, state and national level.

The Law Offices Of Lane & Lane, LLC
230 W Monroe Street, Suite 1900
Chicago, Il 60606
Phone: 312-957-4656
Toll Free: 877-585-7311
Website: www.lane-lane.com

[Attachments] See images for this press release:
Cerebral Palsy Effects Might Be Lessened By New Drug Treatment

ELSE PRESS RELEASES FROM THIS DATE:

Studies challenge established views development of children raised by gay or lesbian parents

2012-06-11
Oxford, June 10, 2012 - Despite considerable research showing that children of same-sex parents fare just as well as children with heterosexual parents, two papers - a review of existing studies and a new study - published today in Elsevier's Social Science Research, find insufficient data to draw any definitive conclusions. The review by Dr. Loren Marks from Louisiana State University finds that much of the science that forms the basis for the highly regarded 2005 official brief on same-sex parenting by the American Psychological Association (APA) (http://www.apa.org/pi/lgbt/resources/parenting-full.pdf) ...

Researchers watch tiny living machines self-assemble

Researchers watch tiny living machines self-assemble
2012-06-11
Enabling bioengineers to design new molecular machines for nanotechnology applications is one of the possible outcomes of a study by University of Montreal researchers that was published in Nature Structural and Molecular Biology today. The scientists have developed a new approach to visualize how proteins assemble, which may also significantly aid our understanding of diseases such as Alzheimer's and Parkinson's, which are caused by errors in assembly. "In order to survive, all creatures, from bacteria to humans, monitor and transform their environments using small protein ...

XCOR Aerospace Announces Space Expedition Corporation (SXC) As General Sales Agent For Space Tourism Flights

2012-06-11
With the Tom Sachs space-themed art exhibit, "Space Program: Mars" as a backdrop, XCOR Aerospace named Space Expedition Corporation (SXC) as the new General Sales Agent (GSA) for the XCOR owned Lynx Suborbital vehicle flying from the Mojave Air and Spaceport. SXC was previously announced as the first wet lease customer for a Lynx production vehicle with planned flights from Curacao. The GSA places the responsibility with SXC for ticket sales through the extensive network of XCOR Space Tourism Specialists and for astronaut training and relations for XCOR Lynx flights ...

Smiles at Fairfax Corner Unveils New Office Video Tour

Smiles at Fairfax Corner Unveils New Office Video Tour
2012-06-11
The Fairfax dentists unveil a new office video tour, which viewers can find on the Smiles at Fairfax Corner website. The video tour displays the incredible amenities and beautiful office environment that Dr. Riaz Rayek offers to patients. The new office video tour provides viewers with an in-depth depiction of everything Smiles at Fairfax Corner has to offer. From the welcoming, relaxing reception area to a look into the treatment rooms filled with high-tech dental equipment, Dr. Rayek guides viewers through the various facets of the office. You can also see the dental ...

Decoding DNA finds breast tumor signatures that predict treatment response

Decoding DNA finds breast tumor signatures that predict treatment response
2012-06-11
Decoding the DNA of patients with advanced breast cancer has allowed scientists to identify distinct cancer "signatures" that could help predict which women are most likely to benefit from estrogen-lowering therapy, while sparing others from unnecessary treatment. Researchers at Washington University School of Medicine in St. Louis uncovered mutations linked to whether or not women respond to aromatase inhibitors, drugs often prescribed to shrink large tumors before surgery. These mutations also correlate with clinical features of breast tumors, including how likely they ...

Homeland Security Network (HSN) Announces Interface to Accommodate Growing Membership

Homeland Security Network (HSN) Announces Interface to Accommodate Growing Membership
2012-06-11
The Homeland Security Network has just completed a face-lift that will make it easier and quicker to use the site. The new home page gives user's clear options on where to go to get free educational webinars, educational movies, DVDs, News, Resources and lots more. "Everybody concerned with protecting the USA knows that the dots get connected when information from many different agencies is fused. The Homeland Security Network is like a private Facebook, with a big difference. It is only for hand-verified members of the US First Responder agencies or private security ...

Undersea volcano gave off signals before eruption in 2011

2012-06-11
NEWPORT, Ore. – A team of scientists that last year created waves by correctly forecasting the 2011 eruption of Axial Seamount years in advance now says that the undersea volcano located some 250 miles off the Oregon coast gave off clear signals hours before its impending eruption. The researchers' documentation of inflation of the undersea volcano from gradual magma intrusion over a period of years led to the long-term eruption forecast. But new analyses using data from underwater hydrophones also show an abrupt spike in seismic energy about 2.6 hours before the eruption ...

Scripps Research scientists develop new tools to unveil mystery of the 'glycome'

Scripps Research scientists develop new tools to unveil mystery of the glycome
2012-06-11
LA JOLLA, CA – June 10, 2012 – Scientists at The Scripps Research Institute have developed chemical compounds that can make key modifications to common sugar molecules ("glycans"), which are found on the surface of all cells in our body. The new study presents powerful new tools for studying these molecules' function, for example in cell signaling and immunity, and for investigating new treatments for chronic inflammation, autoimmune diseases, cancer metastasis, and related conditions. The new study, which appears online in Nature Chemical Biology on June 10, 2012, describes ...

Researchers found 4 gene loci predisposing people to the most common subtype of migraine

2012-06-11
Researchers studied genetic data of more than 11 000 people and found altogether six genes that predispose to migraine without aura. Four of these genes are new and two of them confirm previous findings. The new genes identified in this study provide further evidence for the hypothesis that dysregulation of molecules important in transmitting signals between brain neurons contribute to migraine. Two of the genes support the hypothesis of a possible role of blood vessels and thus disturbances in blood flow. The researchers carried out what is known as a genome-wide ...

High-Tech Meets Live Music as Concertboom Launches out of Beta Version

2012-06-11
Concertboom is launching the public version of its live music database, offering a top-class portal for the global concert and ticketing industries. Concertboom provides the most accurate live-music data information, in the fastest possible time and features a simple, desirable appearance and feel with a revolutionary two-click motion that gives live music lovers worldwide access to a database that spans all musical genres. Recently highlighted by Google AdSense for top-ranking positions and strategic marketing within the music industry space, Concertboom is an early ...

LAST 30 PRESS RELEASES:

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

UNC-Chapel Hill study shows AI can dramatically speed up digitizing natural history collections

OYE Therapeutics closes $5M convertible note round, advancing toward clinical development

Membrane ‘neighborhood’ helps transporter protein regulate cell signaling

Naval aviator turned NPS doctoral student earns national recognition for applied quantum research

[Press-News.org] Cerebral Palsy Effects Might Be Lessened By New Drug Treatment
Cerebral palsy is a lifelong disorder affecting about one out of 300 children in the United States. It characteristically affects movement control, causing muscles to stiffen or jerk.